ORMP

2.15

2.27% -0.05

Dopo l'orario di chiusura: 2.15

Oramed Pharmaceuticals Inc (ORMP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.20

Aprire:

$2.2

Volume 24 ore:

113.17K

Relative Volume:

0.99

Capitalizzazione di mercato:

$87.83M

Reddito:

$2.70M

Utile/perdita netta:

$5.53M

Rapporto P/E:

19.55

EPS:

0.11

Flusso di cassa netto:

$-10.55M

1 W Prestazione:

-4.44%

1M Prestazione:

-2.27%

6M Prestazione:

-3.59%

1 anno Prestazione:

-7.73%

Intervallo 1D:

$2.09

$2.29

Intervallo di 1 settimana:

$2.09

$2.35

Portata 52W:

$1.82

$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Nome

Oramed Pharmaceuticals Inc

Settore

Healthcare (1170)

Industria

Biotechnology (671)

Telefono

646-844-1164

Indirizzo

1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY

Dipendente

Cinguettio

@OramedPharma

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

ORMP's Discussions on Twitter

Confronta ORMP con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ORMP Oramed Pharmaceuticals Inc	2.15	91.91M	2.70M	5.53M	-10.55M	0.11
ONC Beigene Ltd Adr	228.38	25.07B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	438.65	109.14B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.27	36.39M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	594.32	56.98B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	71.31	5.39B	0	-153.72M	-103.81M	-2.00

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-01-12	Downgrade	Canaccord Genuity	Buy → Hold
2022-02-18	Iniziato	Cantor Fitzgerald	Overweight
2021-04-20	Iniziato	Canaccord Genuity	Buy
2021-02-09	Iniziato	National Securities	Buy
2020-12-03	Iniziato	Alliance Global Partners	Buy
2020-03-11	Iniziato	Aegis Capital	Buy
2019-09-11	Iniziato	Ladenburg Thalmann	Buy
2017-12-11	Ripresa	B. Riley FBR, Inc.	Buy
2016-05-26	Reiterato	FBR Capital	Outperform
2015-12-01	Reiterato	H.C. Wainwright	Buy
2015-11-19	Iniziato	FBR Capital	Outperform
2015-04-13	Ripresa	MLV & Co	Buy
2014-01-30	Reiterato	Aegis Capital	Buy
2014-01-08	Reiterato	Aegis Capital	Buy
2014-01-08	Iniziato	MLV & Co	Buy
2013-12-03	Iniziato	Aegis Capital	Buy

Mostra tutto

Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie

May 15, 2025

Oramed: Q1 Earnings Snapshot - MySA

May 15, 2025

May 13, 2025

Alpha Tau Medical appoints new board member By Investing.com - Investing.com India

May 13, 2025

May 12, 2025

Alpha Tau Medical appoints new board member - Investing.com

May 12, 2025

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - GlobeNewswire

May 12, 2025

Apr 29, 2025

Oramed Invests $36.9 Million In Alpha Tau For Strategic Growth - Finimize

Apr 29, 2025

Alpha Tau Medical (DRTS) Secures $36.9M in Direct Offering with Oramed Pharmaceuticals | DRTS Stock News - GuruFocus

Apr 29, 2025

Apr 28, 2025

Oramed invests $36.9 million in Alpha Tau cancer therapy By Investing.com - Investing.com

Apr 28, 2025

Alpha Tau Closes $36.9 Mln Offering And Forms Strategic Alliance With Oramed Pharmaceuticals - Nasdaq

Apr 28, 2025

Oramed Pharmaceuticals Announces $36.9 Million Investment And Strategic Collaboration With Alpha Tau Medical - marketscreener.com

Apr 28, 2025

Alpha Tau Announces Closing of $36.9 Million Registered - GlobeNewswire

Apr 28, 2025

Major Biotech Deal: Alpha Tau Medical Secures $36.9M Investment to Accelerate Cancer Treatment Innovation - Stock Titan

Apr 28, 2025

Oramed Closes $36.9M Strategic Investment in Alpha Tau Medical - citybiz

Apr 28, 2025

Alpha Tau's $37M Deal Unlocks Major Growth: 4 US Trials and Marketing Alliance Signal Expansion - Stock Titan

Apr 28, 2025

Apr 25, 2025

Oramed stock hits 52-week low at $1.95 amid market challenges - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

Oramed stock hits 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Mar 27, 2025